Optimisation of cost effectiveness through Individualised FSH Stimulation dosages for IVF Treatment: The OPTIMIST trial.

Optimisation of cost effectiveness through Individualised FSH Stimulation dosages for IVF Treatment: The OPTIMIST trial. - The OPTIMIST trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON38129

Enrollment

1500

Registered

2011-02-07

Start date

2011-05-12

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility Subfertility

Interventions

All women will undergo assessment of their ovarian reserve using the Antral Follicle Count (AFC) for prediction of poor response or high response. Women with a predicted poor response will be random

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Regular indication for IVF or IVF-ICSI - Female age

Exclusion criteria

Exclusion criteria: - Oocyte donation - Medical contra indication for pregnancy or IVF treatment - Polycystic Ovary Syndrome (PCOS) - Untreated endocrine or metabolic abnormalities (pituitary, adrenal, pancreas, liver or kidney)

Design outcomes

Primary

Measure	Time frame
The primary outcome will be live birth and costs based on previous calculations of the various study procedures	—

Secondary

Measure	Time frame
Secondary outcomes will be poor ovarian response, hyperresponse, cycle cancellation rates, number of cycles needed per live birth.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)